Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
enabled [disable] Abstract
Number of results

Results found: 9

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  susceptibility
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
World-wide, urinary tract infections (UTIs) are an important clinical problem. In such, the most frequently isolated uropathogen is Escherichia coli. In the treatment of uncomplicated UTIs, e.g. cystitis, the widely used antibiotics are nitrofurantoin, trimethoprim/sulfamethoxazole, fosfomycin trometamol or ciprofloxacin, while the treatment of pyelonephritis requires the usage of antibiotics with a broader spectrum of activity, such as cephalosporins of the 3rd and 4th generation, aminoglycosides or even carbapenems. The aim of this study was to assess the susceptibility to aminoglycosides (such as amikacin, gentamicin, netilmicin and tobramycin) of E. coli isolated from UTIs in adult community patients living in Lubelszczyzna. We found that all of the 86 strains of E. coli encountered were susceptible to amikacin. Moreover, the prevalence of susceptibility to tobramycin, gentamicin or netilmicin among the tested strains was found to be 89,5%, 90,7% or 94,2%, respectively. The data obtained in the present study shows the high susceptibility to aminoglycosides of E. coli isolated from the community-acquired UTIS in adults. These data, together with that derived from current literature, indicate that aminoglycosides, when employed in combination therapy with other antibiotics, may still be very useful group of antibacterial agents in the treatment of UTI’s in Poland.
EN
The aim of the date was to determine the sensitivity to chitosan ascorbate microaerophilic bacteria isolated from pathological pockets, root canals and apical abscesses. Chitosan was obtained from Antarctic krill. The experiments included 70 clinical isolates and 4 standards strains. The susceptibility of microaerophilic bacteria was performed by means of plate dilution technique in Brucella agar supplemented with 5% defibrinated sheep blood. Inoculum contained 105 CFU per spot. Incubation inoculated agar was performed at 37°C for 48 hrs in microaerophilic conditions. MIC was defined as the least concentrations of chitosan ascorbate that inhibited growth of tested bacteria. The results indicated that 47% of all date bacteria was susceptible to chitosan ascorbate in ranges ≤ 0.01 – 0.5 mg/ml. The most susceptible were the strains of Corynebacterium matruchotii (100%, MIC ≤ 0.01 – 0.5 mg/ml) and the least sensitive strains of Rothia dentocariosa (MIC in ranges 1.0 ˗ ≥ 4.0 mg/ml ).
EN
The magnetic investigations of potassium holmium double tungstate KHo(WO4)2 have been performed. The results of measurements of magnetic susceptibility and magnetization as a function of both temperature (T = 0.5–100 K) and magnetic field (up to 2 T) are presented.
EN
The aim of the study was determine activity of chitosan ascorbate against 17 strains of Helicobacter pylori. The strains were isolated from gingival pockets (7 strains), atherosclerotic plaques from carotid and femoral (10 strains). Chitosan was obtained from krill chitin and deacetylation degree was equal 60%. The ratio of ascorbic to chitosan was equal 1. The susceptibility of rods was determined by means of plate dilution technique in Brucella agar with 5% sheep’s blood. The inoculum contained 105 CFU/spot. Incubation was performed in anaerobic jars with Campy Pak (BBL) for 48 hrs. The MIC was interpreted as the lowest concentration of chitosan ascorbate inhibiting the growth of bacteria. The results indicated, that chitosan ascorbate at the lowest concentrations was active against 35% of the strains. The Helicobacter pylori rods isolated from gingival pockets were the highest susceptible than isolated from atherosclerotic plaques.
|
|
issue 4
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.